EBS
Emergent BioSolu (EBS)
NYSE
$8.45+$0.31 (+3.80%)
Price as of Jun 18, 2026 4:30 AM EDT
  • $399.9M
    Market Cap
  • 29.00%
    1-Year Change
  • Drug Manufacturers - Specialty & Generic
    Industry

Earnings Score

Score: 64
Valuation
EBS
vs History
vs S&P 500
Profitability
0
Growth
0
Low Earnings Volatility
0

Momentum Score

Score: 52
Valuation
EBS
vs History
vs S&P 500
3-Month Momentum
-2.40%
12-Month Momentum
30.71%
3-Month Risk Adjusted Momentum
-11.69%
12-Month Risk Adjusted Momentum
38.17%

True Yield

N/A
Valuation
EBS
vs History
vs S&P 500
Dividend Yield
N/A
Net Buyback Yield
4.20%
Net Debt Paydown Yield
-0.33%

Financial Health Score

Score: 56
Valuation
EBS
vs History
vs S&P 500
Ohlson's O-Score
6